Comment by
Harper75 on Sep 13, 2023 12:35pm
They had opportunity to change the timeline with the July update...that made me think they must be confident with only 2months remaining in the Quarter.
Comment by
MrMugsy on Sep 13, 2023 5:59pm
Not IBD but a new molecule was planned to be introduced in Q3. Don't expect it until Q4.
Comment by
Harper75 on Sep 14, 2023 12:32pm
Q3 still has some daylight but a delay to Q4 (or later...?) at this point chips away at the remaining confidence I had in the Antibe team. WTH are we to think if they are unable to meet deadlines updated 60days out.
Comment by
MrMugsy on Sep 15, 2023 12:37am
It isn't about hitting or missing timelines - it's about choosing "when" to release. Lets wait for A before we do B.
Comment by
Harper75 on Sep 15, 2023 3:32pm
I agree that strategic "A vs B" should go into the timeline narrative but I disagree that missing milestones is of no consequence. Devise the plan...communicate the plan...execute to plan. I'm old fashioned that way...
Comment by
Harper75 on Sep 19, 2023 9:01am
Hey Mugsy - thanks for the detailed reply. Delays are to be expected - no arguments here. I was calling out any Corporate update should be be able to forecast accuratly 60-90days out with more uncertainty the further out the timeline. Perhaps I'm overly anxious for the positive new cycle to re-start after riding this wave for too many years.